Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Muyesar Alifu"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionRecent clinical trials have confirmed that anti-programmed cell death-1/ligand 1 (anti-PD-1/L1) combined with either anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4) or anti-T-cell immunoreceptor with Ig and ITIM domains (TI
Externí odkaz:
https://doaj.org/article/49f74df776474d4199182700d35d4f7b
